Lyndra therapeutics announces strategic clinical research and commercial manufacturing services collaboration with thermo fisher scientific for long-acting oral therapies

Watertown, mass.--(business wire)--lyndra therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with thermo fisher scientific inc., the world leader in serving science, in which thermo fisher will provide global clinical research and commercial manufacturing services to lyndra for its long-acting oral therapies. lyndra's long-acting oral therapies, including lead investigational product oral weekly risperidone (.
TMO Ratings Summary
TMO Quant Ranking